| Literature DB >> 35150912 |
Gabriel Birgand1, Esmita Charani2, Raheelah Ahmad3, Candice Bonaconsa4, Oluchi Mbamalu4, Vrinda Nampoothiri5, Surya Surendran5, Tom G Weiser6, Alison Holmes7, Marc Mendelson4, Sanjeev Singh5.
Abstract
This article summarizes the consequences of the COVID-19 pandemic, on an international project to tackle antimicrobial resistance (AMR). The research leadership and process, the access to data, and stakeholders were deeply disrupted by the national and international response to the pandemic, including the interruption of healthcare delivery, lockdowns, and quarantines. The key principles to deliver the research through the pandemic were mainly the high degree of interdisciplinary engagement with integrated teams, and equitable partnership across sites with capacity building and leadership training. The level of preexisting collaboration and partnership were also keys to sustaining connections and involvements throughout the pandemic. The pandemic offered opportunities for realigning research priorities. Flexibility in funding timelines and projects inputs are required to accommodate variance introduced by external factors. The current models for research collaboration and funding need to be critically evaluated and redesigned to retain the innovation that was shown to be successful through this pandemic.Entities:
Keywords: COVID-19; Capacity building; LMICs; antimicrobial resistance; research; resilience
Mesh:
Substances:
Year: 2022 PMID: 35150912 PMCID: PMC8826599 DOI: 10.1016/j.ijid.2022.02.013
Source DB: PubMed Journal: Int J Infect Dis ISSN: 1201-9712 Impact factor: 12.074
Summary of pandemic issues
| Pandemic related issues | Level | Potential impacts | Mitigation/Response |
|---|---|---|---|
| Interruption to healthcare delivery | On-site research teams (LMIC) | Interruption of elective surgeryDisrupting in the implementation of intervention | Use the time for an intermediate analysis to improve the implementation process when the clinical activity restarts.Use the time to plan and co-design of interventions. |
| Limited availability of IPC and AMS specialists | Engage specialists by realigning the research toward COVID-19 priorities. | ||
| Research leadership and process | On-site research teams (LMIC) and UK research teams | Principal investigators and clinical researchers largely drawn to front line strategic and operational tasks | Leadership training for early career researchers.Development of a network of research management connecting junior staff to each other in different sites.Setting up regular monitoring or mentoring through different media.Encouraging junior researchers to support each other and learn from each other / to learn from and support each otherMatching staff with previous field experience to manage junior researchers remotely. |
| Lack of communication and connections, decline in clinician's willingness and motivation to contribute in the research | Spending time on research site at the initial stage of the projectStaff and meetings shared across LMICs sites.Day to day dialogue and meetings between junior researchers from each site (i.e. video conferences, network servers).Keep the momentum, remaining remotely connected by regular and iterative meetings with clinicians. | ||
| All levels | Local or national lockdowns and quarantines compromising on-site visits and physical meetings | Organize online workshops for co-designing interventions, to discuss on the research project. | |
| Access to data and stakeholders | On-site research teams (LMIC) | Decreased on-site access to clinicians (surgeons) | Interruptions of elective surgery offered the opportunity to organize remotely reciprocal partnerships with surgeons, share learning on IPC and AMR from data collected during the pre-COVID-19 phase of the project. |
| On-site research teams (LMIC) | Poor access to sites for local non-clinician researchers, compromising the data collection | Build collaboration with on-site managers/workers. | |
| Shift in research priorities globally | Global/whole project | Diversion of resources from AMR prevention to COVID-19 research. | Research project reorientations to reconcile the project aim with the local priorities. |
| Global/whole project | Delays in funded research | Flexibility in funding timelines and project outputs. |
Observations and Potential Strategies to Further Mitigate the impact of COVID-19 on an international research project on AMR.